Publications by authors named "Scott Grindrod"

Claim this Profile
D
Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth.
Mira Jung, Nicole Nicholas, Scott Grindrod, Anatoly Dritschilo

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition.
Satish Kumar R Noonepalle, Scott Grindrod, Nima Aghdam, Xintang Li, Maria Gracia-Hernandez

Mol Cancer Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers.
Amrita K Cheema, Yaoxiang Li, Mary Ventimiglia, Keith Kowalczyk, Ryan Hankins, Scott Grindrod

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.
Mira Jung, Keith Kowalczyk, Ryan Hankins, Gaurav Bandi, Bhaskar Kallakury, Scott Grindrod

Cancer Res Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen Substituted Nucleosides Combined with Proton Beam Therapy: Therapeutic Transmutation In Vitro.
Tyvin Rich, Dongfeng Pan, Mahendra Chordia, Cynthia Keppel, David Beylin, Scott Grindrod

Int J Part Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Metabolic Biomarkers Predicting Radiation Therapy Late Effects in Prostate Cancer Patients.
Amrita K Cheema, Scott Grindrod, Xiaogang Zhong, Shreyans Jain, Smrithi S Menon

Adv Exp Med Biol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery.
Antoinette Cordova, Jordan Woodrick, Scott Grindrod, Li Zhang, Yasemin Saygideger-Kont

Bioconjug Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α.
Yongxian Ma, York Tomita, Anju Preet, Robert Clarke, Erikah Englund, Scott Grindrod

Mol Endocrinol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel carbazole inhibits phospho-STAT3 through induction of protein-tyrosine phosphatase PTPN6.
Shujie Hou, Yong Weon Yi, Hyo Jin Kang, Li Zhang, Hee Jeong Kim, Scott Grindrod

J Med Chem· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent.
Thomas H Walls, Scott C Grindrod, Dawn Beraud, Li Zhang, Aparna R Baheti

Bioorg Med Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells.
Scott Grindrod, Simeng Suy, Shannon Fallen, Masumi Eto, Jeffrey Toretsky

Front Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor.
Yali Kong, Mira Jung, Kan Wang, Scott Grindrod, Alfredo Velena

Mol Cancer Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
Venkata Mahidhar Yenugonda, Tushar B Deb, Scott C Grindrod, Sivanesan Dakshanamurthy, Yonghong Yang

Bioorg Med Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.
Lymor Ringer, Paul Sirajuddin, Venkata Mahidhar Yenugonda, Anup Ghosh, Kyle Divito, Scott Grindrod

Cancer Biol Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft.
Kathryn D Sheikh, Partha P Banerjee, Shankar Jagadeesh, Scott C Grindrod, Li Zhang

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of C-glycoside analogues of beta-galactosamine-(1-->4)-3-O-methyl-D-chiro-inositol and assay as activator of protein phosphatases PDHP and PP2Calpha.
Sunej K Hans, Fatoumata Camara, Ahmad Altiti, Alejandro Martín-Montalvo, David L Brautigan, Scott Grindrod

Bioorg Med Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetric synthesis of 2,3-dihydro-2-arylquinazolin-4-ones: methodology and application to a potent fluorescent tubulin inhibitor with anticancer activity.
Gary M Chinigo, Mikell Paige, Scott Grindrod, Ernest Hamel, Sivanesan Dakshanamurthy

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meso-substituted [34]octaphyrin(1.1.1.0.1.1.1.0) and corrole formation in reactions of a dipyrromethanedicarbinol with 2,2'-bipyrrole.
G Richard Geier, Scott C Grindrod

J Org Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis